ImmunoGen Company
.jpg)
ImmunoGen engages in the research and development of antibody-based anticancer therapeutics using its targeted antibody payload technology.
Headquarters:
Waltham, Massachusetts, United States
Estimated Revenue:
$10M to $50M
Founded Date:
1981-01-01
Industry:
Women Cancer Treatment